干预性维生素C:减轻猪多发伤模型中凝血功能障碍和炎症的策略
该研究为前瞻性随机对照盲法动物实验,纳入24头雄性Sinclair猪(平均体重27 kg),建立休克/创伤模型(低体温、肝缺血再灌注、股骨粉碎性骨折、失血性低血压),用500 mL羟乙基淀粉复苏后随机分为生理盐水组、低剂量维生素C组(50 mg/kg)和高剂量维生素C组(200 mg/kg)。结果显示,与维生素C组相比,生理盐水组出现显著的组织学终末器官损伤、急性肺损伤评分升高以及组织促炎介质(IL-1β、IL-8、TNFα)、纤溶酶原激活物抑制剂-1和组织因子的mRNA表达增加;各组平均动脉压或单变量凝血功能指标无统计学显著差异,但生理盐水组在4小时时多元凝血功能受损。作者认为,静脉高剂量维生素C虽对凝血功能障碍纠正作用有限,但可能减轻急性严重多发伤后促炎/促凝反应。
要点
- 在猪多发伤出血模型中,与维生素C组相比,生理盐水组出现显著组织学终末器官损伤和急性肺损伤评分升高。
- 生理盐水组组织促炎介质(IL-1β、IL-8、TNFα)、纤溶酶原激活物抑制剂-1和组织因子mRNA表达较维生素C组增加。
- 各组平均动脉压或单变量凝血功能指标无统计学显著差异,但生理盐水组4小时多元凝血功能受损。
- 静脉高剂量维生素C(200 mg/kg)可能减轻促炎/促凝反应,但对凝血功能障碍纠正作用有限。
适用人群与场景
- 雄性Sinclair猪(n=24;平均体重27 kg),建立休克/创伤模型:低体温、肝缺血再灌注、股骨粉碎性骨折、失血性低血压。
处置流程与药物剂量
- 动物麻醉、插管、机械通气并连接生理监测后,建立休克/创伤模型,用500 mL羟乙基淀粉复苏。
- 随机给予静脉生理盐水、低剂量维生素C(50 mg/kg)或高剂量维生素C(200 mg/kg)。
- 复苏后监测血流动力学、血液化学、血液学和凝血功能(ROTEM)至4小时,并对肝、肾、肺进行组织学和分子分析。
研究设计与关键结果
- 研究类型:前瞻性随机对照盲法动物实验;样本量n=24头雄性Sinclair猪;人群:多发伤出血模型。
- 干预与对照:生理盐水组 vs 低剂量维生素C(50 mg/kg) vs 高剂量维生素C(200 mg/kg),均静脉给药。
- 主要终点结果:与维生素C组相比,生理盐水组出现显著组织学终末器官损伤、急性肺损伤评分升高,以及组织促炎介质(IL-1β、IL-8、TNFα)、纤溶酶原激活物抑制剂-1和组织因子mRNA表达增加。
- 关键次要终点:各组平均动脉压或单变量凝血功能指标无统计学显著差异;生理盐水组4小时多元凝血功能受损。
证据类型、等级与局限
- 证据类型:前瞻性随机对照盲法动物实验(临床前,动物-based);证据等级:原文标注Preclinical(animal-based)。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,静脉高剂量维生素C可能减轻急性严重多发伤后促炎/促凝反应,虽对凝血功能障碍纠正作用有限。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Coagulopathy and inflammation induced by hemorrhagic shock and traumatic injury are associated with increased mortality and morbidity. Vitamin C (VitC) is an antioxidant with potential protective effects on the proinflammatory and procoagulant pathways. We hypothesized that high-dose VitC administered as a supplement to fluid resuscitation would attenuate inflammation, coagulation dysfunction, and end-organ tissue damage in a swine model of multiple injuries and hemorrhage.
METHODS: Male Sinclair swine (n = 24; mean body weight, 27 kg) were anesthetized, intubated, mechanically ventilated, and instrumented for physiologic monitoring. Following stabilization, swine were subjected to shock/traumatic injury (hypothermia, liver ischemia and reperfusion, comminuted femur fracture, hemorrhagic hypotension), resuscitated with 500 mL of hydroxyethyl starch, and randomized to receive either intravenous normal saline (NS), low-dose VitC (50 mg/kg; LO), or high-dose VitC (200 mg/kg; HI). Hemodynamics, blood chemistry, hematology, and coagulation function (ROTEM) were monitored to 4 hours postresuscitation. Histological and molecular analyses were obtained for liver, kidney, and lung.
RESULTS: Compared with VitC animals, NS swine showed significant histological end-organ damage, elevated acute lung injury scores, and increased mRNA expression of tissue proinflammatory mediators (IL-1β, IL-8, TNFα), plasminogen activation inhibitor-1 and tissue factor. There were no statistically significant differences between treatment groups on mean arterial pressure or univariate measures of coagulation function; however, NS showed impaired multivariate clotting function at 4 hours.
CONCLUSION: Although correction of coagulation dysfunction was modest, intravenous high-dose VitC may mitigate the proinflammatory/procoagulant response that contributes to multiple organ failure following acute severe multiple injuries.
LEVEL OF EVIDENCE: Prospective randomized controlled blinded trial study, Preclinical (animal-based).
参考来源
- Reynolds PS, Fisher BJ, McCarter J, et al. Interventional vitamin C: A strategy for attenuation of coagulopathy and inflammation in a swine multiple injuries model. J Trauma Acute Care Surg. 2018. PMID: 29538225. doi:10.1097/TA.0000000000001844
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。